Another aspect of the action of trimetazidine mechanism that may be crucial for people with cardiovascular disease, including those who have chronic heart failure (CHF), is its direct suppression of cardiac fibrosis through enhancing connective tissue growth factor (CTGF) [13]. The gene discussed is CCN2; the disease is congestive heart failure.